Not against BP, we will most likely complement what they have in their pipelines. We compete with other non commercial preclinical research labs and smaller biotechs. We were in the same boat now as we were with with HepC development, BP will have their own tech but probably require further IP from smaller operations such as Gilead did with sofosbuvir. It's competitive.
- Forums
- ASX - By Stock
- BIT
- $10 Billion Deal
$10 Billion Deal, page-11927
-
- There are more pages in this discussion • 1,341 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.002(6.67%) |
Mkt cap ! $28.87M |
Open | High | Low | Value | Volume |
3.1¢ | 3.3¢ | 3.1¢ | $13.79K | 424.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 329429 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 329429 | 0.032 |
3 | 81516 | 0.031 |
8 | 342305 | 0.030 |
3 | 1008888 | 0.029 |
4 | 468000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 100000 | 1 |
0.035 | 347547 | 4 |
0.037 | 537816 | 2 |
0.038 | 162500 | 1 |
0.039 | 317353 | 2 |
Last trade - 15.51pm 26/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |